Allosteric inhibitors of telomerase: Oligonucleotide N3‘→P5’ phosphoramidates

Nucleic Acids Research

Volumn 30, Issue 2, 2002, Pages 559-568

  Pruzan, Ronald ^a   Pongracz, Krisztina ^a   Gietzen, Kimberly ^a   Wallweber, Gerald ^a   Gryaznov, Sergei ^a  

^a GERON CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; GUANINE; MUTANT PROTEIN; NUCLEOTIDE; OLIGONUCLEOTIDE; PHOSPHORAMIDIC ACID DERIVATIVE; PRIMER DNA; RIBONUCLEOPROTEIN; RNA; SINGLE STRANDED DNA; TELOMERASE; TELOMERASE INHIBITOR; THYMINE;

ALLOSTERISM; ARTICLE; CANCER THERAPY; CELL CULTURE; CELL PROLIFERATION; CHEMICAL ANALYSIS; CHROMOSOME; CONTROLLED STUDY; DOWNSTREAM PROCESSING; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME STRUCTURE; ENZYME SUBSTRATE; EUKARYOTIC CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; TELOMERE; TRINUCLEOTIDE REPEAT;

ALLOSTERIC REGULATION; ALLOSTERIC SITE; AMIDES; ANIMALS; BASE SEQUENCE; CELL LINE; COS CELLS; DNA PRIMERS; DNA, SINGLE-STRANDED; DNA-BINDING PROTEINS; HUMANS; INHIBITORY CONCENTRATION 50; KINETICS; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEIC ACID CONFORMATION; OLIGONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHORIC ACIDS; RECOMBINANT PROTEINS; RNA; TELOMERASE; TEMPLATES, GENETIC; THERMODYNAMICS;

EUKARYOTA;

EID: 0037079670     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/30.2.559     Document Type: Article

References (37)

1. Telomerases
2. Telomerase activity in human germline and embryonic tissues and cells
3. Telomeres, telomerase and aging: Origin of the theory
4. Telomere end-replication problem and cell aging
5. Defining the molecular mechanisms of human cell immortalization
6. SV40-induced transformation of human diploid cells: Crisis and recovery
7. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity
8. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres
9. Longevity, stress response and cancer in aging telomerase-deficient mice
10. Specific association of human telomerase activity with immortal cells and cancer
11. Extension of life-span by introduction of telomerase into normal human cells
12. Dissociation among in vitro telomerase activity, telomere maintenance and cellular immortalization
13. Human endothelial cell life extension by telomerase expression
14. Creation of human tumour cells with defined genetic elements
15. A survey of telomerase activity in human cancer
16. Inhibition of telomerase limits the growth of human cancer cells
17. Secondary structure of vertebrate telomerase RNA
18. Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase
19. A telomerase component is defective in the human disease dyskeratosis congenita
20. In vitro assembly of human H/ACA small nucleolar RNPs reveals unique features of U17 and telomerase RNAs
21. Human H/ACA small nucleolar RNPs and telomerase share evolutionarily conserved proteins NHP2 and NOP10
22. Telomerase reverse transcriptase genes identified in Tetrahymena thermophila and Oxytricha trifallax
23. Reverse transcriptase motifs in the catalytic subunit of telomerase
24. Analysis of telomerase catalytic subunit mutants in vivo and in vitro in Schizosaccharomyces pombe
25. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT
26. The reverse transcriptase component of the Tetrahymena telomerase ribonucleoprotein complex
27. 2-5A antisense telomerase RNA therapy for intracranial malignant gliomas
28. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death
29. Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides
30. Inhibition of human telomerase activity by peptide nucleic acids
31. Oligonucleotide N3′→P5′ phosphoramidates as potential therapeutic agents
32. One-step affinity purification protocol for human telomerase
33. Purification of telomerase from Euplotes aediculatus: Requirement of a primer 3′ overhang
34. SV40-transformed simian cells support the replication of early SV40 mutants
35. The RNA component of human telomerase
36. Reconstitution of human telomerase activity and identification of a minimal functional region of the human telomerase RNA
37. Telomerase inhibitors-oligonucleotide phosphoramidates as potential therapeutic agents